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Longitudinal monitoring of patients suggests a causal link between chronic periodontitis
and the development of Alzheimer’s disease (AD). However, the explanation of how
periodontitis can lead to dementia remains unclear. A working hypothesis links extrinsic
inflammation as a secondary cause of AD. This hypothesis suggests a compromised
oral hygiene leads to a dysbiotic oral microbiome whereby Porphyromonas gingivalis,
a keystone periodontal pathogen, with its companion species, orchestrates immune
subversion in the host. Brushing and chewing on teeth supported by already injured soft
tissues leads to bacteremias. As a result, a persistent systemic inflammatory response
develops to periodontal pathogens. The pathogens, and the host’s inflammatory
response, subsequently lead to the initiation and progression of multiple metabolic and
inflammatory co-morbidities, including AD. Insufficient levels of essential micronutrients
can lead to microbial dysbiosis through the growth of periodontal pathogens such
as demonstrated for P. gingivalis under low hemin bioavailability. An individual’s
diet also defines the consortium of microbial communities that take up residency
in the oral and gastrointestinal (GI) tract microbiomes. Their imbalance can lead to
behavioral changes. For example, probiotics enriched in Lactobacillus genus of bacteria,
when ingested, exert some anti-inflammatory influence through common host/bacterial
neurochemicals, both locally, and through sensory signaling back to the brain. Early
life dietary behaviors may cause an imbalance in the host/microbial endocrinology
through a dietary intake incompatible with a healthy GI tract microbiome later in
life. This imbalance in host/microbial endocrinology may have a lasting impact on
mental health. This observation opens up an opportunity to explore the mechanisms,
which may underlie the previously detected relationship between diet, oral/GI microbial
communities, to anxiety, cognition and sleep patterns. This review suggests healthy
diet based interventions that together with improved life style/behavioral changes may
reduce and/or delay the incidence of AD.
Keywords: Alzheimer’s disease, co-morbidities, diet, endocrine microbiomes, periodontitis
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INTRODUCTION
Alzheimer’s disease (AD) is the most common form of dementia,
constituting 60%–80% of all cases. Due to the rising number
of dementia cases and the paucity of adequate treatment for
AD, emphasis for future management of this disease is on
identification and modification of potential risk factors for AD
onset and progression.
ALZHEIMER’S DISEASE
There are two forms of AD: the inherited form, with known
genetic factors, and the sporadic form, with an unknown cause.
The sporadic form is the focus of this manuscript, as the vast
majority of AD cases fall into this category. Whatever the form
of AD, the overall condition presents clinically with depression
and deteriorating cognition and at post mortem with two
neuropathological hallmark lesions. These lesions are proteins
represented as senile plaques composed of amyloid-beta (Aβ),
and hyperphosphorylated tau protein coated neurofibrillary
tangles. For the sufferer, the course of disease is relentless, and
families shoulder the emotional impact.
While clinically AD is described as ‘‘irreversible memory
loss’’ a recent clinical study of the early intervention MENDTM
protocol demonstrated reversal of the functional loss in the
prodromal AD cases (Bredesen et al., 2016). In this study a small
cohort of patients re-gained memory by avoiding risk factors as
suggested in the MENDTM protocol (Bredesen et al., 2016). The
MENDTM protocol represents proof of concept for modifiable
risks in AD, and supports the concept of risk factor identification
and modification to delay/slow down AD.
Previous research suggests that people of a lower socio-
economic status (SES) and those with a poor education level
and women (Brayne and Calloway, 1990; Chen and Miller, 2013;
Russ et al., 2013) have poorer cognitive functioning in later life
(Marden et al., 2017). This group of individuals would appear
to be most at risk of AD development. Recently, the FINGER
trial study (Rosenberg et al., 2017) demonstrated better cognition
following multi-domain lifestyle intervention in the elderly who
were at risk for developing dementia due to low SES and limited
education. In the Rosenberg et al. (2017) study, intervention
supported changes to ensure a healthy diet, exercise, cognitive
training and management of vascular risk factors. The overall
outcome was encouraging (Rosenberg et al., 2017); however, oral
health status was omitted from their multi-domain risk factor
analysis. One pathway between low SES and premature mortality
is the adoption of unhealthy behaviors, such as smoking and
drinking (Krueger and Chang, 2008; Singh et al., 2013). These
life style behaviors increase periodontal disease manifestation
(Borrell et al., 2006; Persson, 2008; Bonfim et al., 2013) and affect
diseases that are co-morbid with AD (Figure 1).
Dietary choice, in healthy individuals, primarily depends
on the state of a person’s dentition (chewing ability) as
well as on their appetite and craving for a specific type of
food. It is proposed that the microbial endocrine signaling
between the host and gastrointestinal (GI) tract microbiome
neurochemicals also influence appetite related decision-making
(Lyte, 2013, 2014). Therefore, another pathway to support the
importance of behavioral change via the dysbiotic GI tract
microbiome is from a lack of γ-aminobutyric acid (GABA)
expressing bacteria (Foster et al., 2016; see Figure 1). The
healthy brain is abundant in GABAergic neurons, and the host’s
neurotransmitters are known to play diverse roles in regulating
an individual’s behavior (Brown et al., 2008), and to some extent
a holistic wellbeing. Another shared behavioral trait between
microbial endocrinology and human GABA is sleep (Brown
et al., 2008; Galland, 2014, see sleep section). The overall aim
of the current article is to explore the underlying mechanisms
behind the risk factors identified from both periodontal disease
pathogens and GI tract microbiome neuroendocrine mediated
behavioral aspects. Together they may show potential for further
improvements in cognition if a healthy diet, better oral health and
a symbiotic GI microbiome resumes.
PERIODONTAL DISEASE
Periodontal disease refers to a group of oral (aggressive and
chronic) diseases with polymicrobial etiology affecting the tooth
supporting tissues that result from a host’s immune dysbiosis
(Olsen et al., 2017). It is clear that some genetic influence exist
in the likelihood of periodontal disease development (Genco
and Borgnakke, 2013), however, psychosocial and environmental
factors appear more important in its progression. In addition,
psychosocial factors can influence disease onset and progression,
with those reporting higher levels of anxiety being more
susceptible to periodontal disease (Cekici et al., 2014). Anxiety
also contributes to endogenous inflammation (Kim and Jeon,
2017), and by reducing inflammation and oxidative stress levels
of periodontal disease (Waddington et al., 2000), could guard
against AD (Figure 1).
Mechanisms Linking Alzheimer’s Disease
with Periodontitis
The oral risk factors link to periodontal pathogens accessing
the brain (Riviere et al., 2002; Poole et al., 2013). These
environmental factors may have contributed to dementia
development in the elderly. Several studies have supported the
links between life-style choices, specifically engaging with oral
health practices and AD development (Kondo et al., 1994; Stein
et al., 2007; Paganini-Hill et al., 2012; Luo et al., 2015; Ide
et al., 2016). More recently, a Taiwanese study found a strong
link between chronic periodontal disease (exposures of around
10-year period) and AD (Chen et al., 2017). This retrospective
study (Chen et al., 2017) correlates with a previous prospective
study in which circulating antibodies to two oral bacteria were
linked to cognitive deficit 10 years later (Sparks Stein et al., 2012).
SES (poor oral health, smoking, unhealthy diet) factors are very
important when considering infections of the brain. According
to literature, periodontal disease does contribute to systemic
markers of inflammation (Loos, 2005). Research has shown that
systemic inflammatory markers mediate the development of AD
(Schmidt et al., 2002; Holmes et al., 2003; Engelhart et al., 2004;
Kamer et al., 2009; Sparks Stein et al., 2012). This finding is the
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FIGURE 1 | Schematic to show the knock on effect from an oral condition such as periodontitis to the development of co-morbid states in the order of periodontal
disease cardiovascular and Alzheimer’s disease (AD) with input from the metabolic disorder like type 2 diabetes (T2DM). These conditions disturb mental health.
Mitigation through educational programmes and improved lifestyles involving better oral hygiene, cessation of smoking, nutritional intervention especially prebiotics
providing a balance of neurochemicals from the GI-tract-brain-axis. Together with dental intervention, diet and change in life styles potentially will provide improved
cognition. GI tract microbiome having input on the brains health through microbial changes whereby γ-aminobutyric acid (GABA) deficit affects behavior.
Abbreviations: ENS, enteric nervous system; SES, socio-economic status; GI, gastrointestinal.
crucial link that explains the association of periodontal disease
with both the etiology of cardiovascular pathologies (Libby et al.,
2002), and insulin resistance (Craft, 2005). Rather surprisingly,
Escherichia coli K12 possesses insulin that is similar to the
mammalian functional protein (LeRoith et al., 1981). The fact
that E. coli lipopolysaccharide (LPS) in AD brains co-localizes
with Aβ hallmark protein (Zhan et al., 2016; Zhao et al.,
2017) suggests extrinsic sources of insulin have the potential to
contribute to excess insulin and/or its resistance development. It
may be plausible to suggest that microbial endocrinology plays a
role in the development of diabetes in the AD brain.
Shared Risk Factors for Alzheimer’s
Disease and Periodontitis
Aging
Periodontal disease can start early in life and can progress to
chronic periodontitis in the 40–50 year age range (Schätzel
et al., 2009). Studies show a greater severity of disease in
older populations (Tawse-Smith, 2007; Chen et al., 2017) and
an explanation could be related to the periodontal pathogens
becoming easily ‘‘radicalized’’ or dysbiotic (Harding et al.,
2017) due to dietary changes. For example, P. gingivalis is
able to change its lipid A phosphate composition within its
LPS macromolecule, in response to differing environmental
conditions (paucity of micronutrient bioavailability). This can
produce lipid A structures that can differentially activate
Toll-like Receptor 4 (TLR 4; Al-Qutub et al., 2006) creating
an inflammophilic environment for selection of co-species by
dysbiosis and controlling microbial competition. Incidence of
AD exponentially rises with age from 3% among the 65–74-
year age group to almost 50% among those around 85 years and
older.
Diet
Tooth loss may be associated with nutritional deficits as it does
influence food selection (Ship et al., 1996). It is conceivable that
omission of fresh vegetables and fruit from the diet is likely due to
difficulties in biting and chewing, whatever the age that tooth loss
occurs. Tooth loss could therefore lead to a reliance on comfort
foods, rich in carbohydrates and fats that are associated with an
increased risk of cardiovascular disease and stroke. Vascular risk
factors are important in the etiology of dementia, and loss of teeth
has been associated with an increased risk of stroke (Joshipura
et al., 2003), coronary heart disease (Loesche et al., 1998) and
hypertension (Taguchi et al., 2004) and memory loss in later life
(Kondo et al., 1994).
Genetic Predisposition
AD has an inherited early-onset form (O’Brien andWong, 2011):
the late onset form also has high heritability but is also associated
with numerous pathogens, many of which are able to promote
the key features of AD in laboratory models. Interestingly, AD
related genes from Genome Wide Association Studies overlap
with the host genes employed by several pathogens, including
P. gingivalis, suggesting that susceptibility genes and pathogens
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may condition each other’s disease promoting effects (Carter,
2017).
Infection
Periodontal disease is of known polymicrobial etiology, and
patients who eventually suffer from sporadic AD tend to have
repeat infections before their clinical diagnosis of dementia
(Dunn et al., 2005). This is supported by the finding of microbes
in post mortem AD brains (Riviere et al., 2002; Miklossy, 2011,
2015; Emery et al., 2017).
Inflammatory Signaling
An inflammophilic environment is highly desirable for oral
commensals to become pathogenic and to support periodontal
disease initiation and progression under the influence of
P. gingivalis. The LPS of P. gingivalis shows heterogeneity in
the lipid A region, giving rise to two isoforms designated
LPS1435/1449 and LPS1690 (Herath et al., 2013). These isoforms
are responsible for specific immune signal transduction pathways
(NF-κB; p38 MAPK and/or ERK1/2) that differentially activate
cells from different linages (Darveau et al., 1998; Reife et al.,
2006; Ding et al., 2013; Herath et al., 2013). However, the
plausibility of the theory that P. gingivalis LPS orchestrates
differential immune signaling for initiation of distant organ
specific inflammatory pathology also lies in this endotoxin in
relation to cytokine secretion (Darveau et al., 1998). Consuming
omega-3 fatty acids of marine origin (DHA, EPA), polyphenols
and other non-nutritive compounds of fish, vegetables, nuts and
fruit act as anti-inflammatory agents (Calder et al., 2009).
Socio-Economic Status and Low Education
An association between periodontal disease, low SES and AD
has been established (Brayne and Calloway, 1990; Borrell et al.,
2006; Persson, 2008; Bonfim et al., 2013). Exactly how and
why SES is a risk factor for AD is unclear but the assumption
is that SES influences environmental factors, such as smoking
and alcohol habits (Brayne and Calloway, 1990; Russ et al.,
2013). However, Rosenberg et al. (2017) were unable to link
sex, age and education (low SES) to poor cognition in their
multi-domain lifestyle interventional study. One potential reason
Rosenberg et al. (2017) did not find a link between SES risk
factors and AD could be that they did not include oral health
in their intervention. Oral health would have been useful to
include, as low SES shows associations with periodontal disease
manifestation through harboring higher proportions of oral
bacteria with greater virulence. In addition, excessive smoking
and consumption of alcohol is associated with lower SES and
both of these adverse health behaviors can have a negative effect
on oral hygiene (Singh et al., 2013). People who have a lower SES
may also lack the income to seek dental treatment and purchase
oral hygiene measures, rather than it being through a lack of
education.
Research has discovered that low education achievement can
lead to higher levels of periodontal disease, even when adjusting
for age, gender and SES (Borrell et al., 2006). This suggests that
being less educated may be a risk factor, independent of SES
background of the individual. One potential reason for the link
between education level and severe periodontitis may be that
those with a lower level of educational achievement may receive
less information and education regarding how to maintain their
oral health (Park et al., 2016).
Exercise
Chronic inflammation and oxidative stress are major biological
changes seen inherently in the aging process (Cannizzo et al.,
2011). It is suggested that regular exercise has anti-inflammatory
and anti-oxidant effects (Taafe et al., 2000). Regular exercise
and nutrition appear to link with better periodontal health
(Bawadi et al., 2011) and generally through lowering the levels
of peripheral inflammatory markers (Taafe et al., 2000).
Psychomicrobiomics
The GI tract microbiome-brain axis conceptualizes microbial
endocrine contribution as having an influence on emotional
behavior in humans and laboratory animals (Bravo et al., 2011).
Microbes appear to have neurohormones/neurotransmitters that
function in a similar way to those of human hosts. Germ-free
mice are a good model for understanding the GI microbial
endocrinology in relation to stress and stress related hormones
(Sudo et al., 2004). After subjecting germ-free mice to a battery
of psychological testing procedures, they displayed reduced
anxiety-like behavior. Transfer of strain-matched microbes
reversed this phenotype in germ-free mice at an earlier age
(Diaz Heijtz et al., 2011; Clarke et al., 2013). This shows
the importance of symbiotic relationships of the host with
its microbiomes. Maintaining a balance of these microbiomes
is important and achievable through a dietary intake that
supports neurotransmitters/neurohormones and so balances
local activities and maintains health of the host.
Mediating Factor: Gastrointestinal Tract
Microbiome
The oral cavity is important for a number of nutritional functions
that are required for a healthy existence and, as such, links it to
the GI tract. As noted previously, the GI tract microbiome can
affect AD independently of periodontal disease. However, the
GI tract microbial challenges also pose an interesting analogy
through the dysbiotic microbiome concept to the intestinal
mucosal barriers becoming permeable (Daulatzai, 2014).
The hypothalamic-pituitary-adrenal (HPA) axis responds to
periodontal disease polymicrobial infections. Related inputs from
the CNS may modify GI tract function, while inputs from the
alimentary canal can modulate symptom processing via sensory
pathways to the brain. Since AD onset progresses slowly to the
clinical expression, Brandscheid et al. (2017) examined whether
the asymptomatic neuropathology correlated with changing
bacteria in the GI tract of a familial (5xFAD) mouse model.
Interestingly the study found reduced protein breakdown and
this was related to poor trypsin secretions. Lower levels of trypsin
affected this niche as demonstrated by a changing fecal microbial
composition in an age-dependent manner (Brandscheid et al.,
2017). The consequences of a changing gut microbiome are that
specific bacterial species taking up residency may acquire the
potential to break down mucosal barriers.
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Mediating Factor: Insulin Resistance and
Inflammation
The most important underlying metabolic disturbances that
raise the risk for both AD and periodontal disease are
insulin resistance and a state of chronic inflammation. Based
on the variability in the inflammatory component of AD
cases, three main subtypes of this disease are described,
which are distinguishable by metabolic profiling. Two of
these are described as the ‘‘inflammatory’’ type and ‘‘non-
inflammatory’’ type (Bredesen, 2015). The ‘‘inflammatory’’ type
often encompasses an ApoE4 allele carrier, which presents
with markers of systemic and cerebral inflammation such as
C-reactive protein (CRP) and IL-6 levels, insulin resistance and
hyperhomocysteinemia. In the ‘‘non-inflammatory’’ type AD
insulin resistance, hypovitaminosis D, hyperhomocysteinemia
and reduced hormones dominate while indicators of systemic
inflammation are absent. This does not however exclude the
existence of intra-cerebral inflammation. Since the inflammatory
and non-inflammatory subtypes are insulin resistant, and
often FDG-PET scans show temporal parietal reductions in
glucose utilization (Cunnane et al., 2011; Bredesen, 2015), their
management by nutritional support is plausible.
Diet Based Intervention to Support
Mixed-Pathologies
Good nutrition plays an important role in health. The five leading
global risks for mortality appear to be high blood pressure,
tobacco usage, hyperglycemia, physical inactivity and obesity.
Nutrition can address three of these five global risks successfully.
For example, if individuals consume low amounts of plant-
derived foods, they are at increased risk of developing T2DM,
metabolic syndrome, some cancers, and AD (Salas-Salvadó et al.,
2016). Although a relationship between nutrition and AD onset
is proposed, the mechanisms, which may explain how poor
nutrition leads to AD, are incomplete. Here we explore how poor
nutritionmay not only act as a risk factor for poor oral health, but
may also influence the mechanisms that mediate the relationship
between periodontal disease and AD development. Furthermore,
we explore interventions that can support good nutrition.
Risk Factor: Western Diet
The MENDTM protocol is diet based, and shows reversal of the
functional loss in the prodromal AD cases (Bredesen et al., 2016).
This study refers to a cohort (N = 10) of patients who were able
to re-gain memory by avoiding risk factors as suggested in the
MENDTM protocol (Bredesen et al., 2016). However, it is unclear
if all the foods found within a Western diet directly disturb
brain function, or if it is single nutrients or a combination of
different, dietary elements that have an adverse impact on brain
health. For example, there is no strong argument (Ravnskov
et al., 2014; Harcombe et al., 2016), for avoiding saturated fats,
however, when combined with high glycaemic carbohydrates,
saturated fats do have negative health consequences (Varela-
López et al., 2016). However, the prospective PURE cohort study
in 18 countries from five continents found that total fat intake
and individual types of fatty acids are associated with a decreased
risk of total mortality, and saturated fat intake correlates inversely
with risk for strokes, an established risk factor for AD (Dehghan
et al., 2017).
Diet also has an impact on periodontal disease, an established
risk factor for AD (Kamer et al., 2015; Chen et al., 2017; Harding
et al., 2017). Therefore, promoting a healthy diet that supports
good oral health is an important preventative measure for AD.
A recent epidemiological study on a Japanese population showed
a more advanced periodontal disease in people who had a lower
fat intake (Hamasaki et al., 2017). The authors concluded that
a diet low in fat and high in carbohydrates might be associated
with a higher prevalence of periodontal disease. On the other
hand, the consumption of vegetables, fruit, β-carotene, vitamin
C, β-tocopherol, EPA and DHA helped patients to reduce their
levels of periodontal disease (Dodington et al., 2015).
For the prevention of insulin resistance and inflammation,
diets high in monounsaturated (e.g., olive oil, avocados,
macadamias, chicken fat) and omega-3 polyunsaturated fatty
acids of marine origin are recommended, e.g., a Mediterranean
style diet (Schwingshackl and Hoffmann, 2014). Epidemiological
and interventional studies have repeatedly shown superior
outcomes in weight loss (Hession et al., 2009), weight
maintenance (Larsen et al., 2010), insulin resistance, triglyceride
lowering and HDL cholesterol raising (Shai et al., 2008; Bazzano
et al., 2014), and lowering of CRP (Bazzano et al., 2014)
with lower carbohydrate diets containing more protein and
fat. The same applies for the adoption of a Mediterranean
type diet, which by definition is not low in fat (Schwingshackl
and Hoffmann, 2014). The PREDIMED intervention trial
in individuals with elevated cardiovascular risk compared a
Mediterranean eating pattern supplemented with olive oil or
nuts with a lower fat diet. The results showed significantly
lower numbers of cardiovascular events in those who ate the
diets supplemented with nuts or olive oil (Estruch et al., 2013)
and slower cognitive decline (Estruch et al., 2013; Martínez-
Lapiscina et al., 2013). In addition, foods high in important
micronutrients, such as omega-3 fatty acids, vitamins C, D,
E, B12 and B6, zinc, iron, iodine and magnesium, potassium,
magnesium and dietary fiber can support brain health (Cunnane,
2006).
Beside their negative impact on insulin resistance and
inflammation, diets high in simple carbohydrates may impair
the integrity of the BBB (Hsu and Kanoski, 2014). Compromised
BBB function in individuals susceptible to periodontitis will allow
microbes to enter the brain and this could increase the chances
of developing AD. Adopting a healthier Mediterranean style diet
(Schwingshackl and Hoffmann, 2014), or eating fish, vegetables,
nuts, cocoa and a variety of berries (Poulose et al., 2014), which
are rich in antioxidants and have anti-inflammatory properties,
may help to reduce gingival inflammation. Therefore, a diet,
which reduces inflammation and insulin resistance, may help to
maintain oral and brain health and thus may reduce the risk of
AD (Singh et al., 2014).
Risk Factor: Vitamins
Vitamins are an important element of a well-balanced diet
and vitamin deficits can have important consequences for both
periodontal disease and cognitive performance. Epidemiological
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studies show that low serum levels of 25-hydroxyvitamin D
(25OHD) are associated with increased risk of dental caries
and periodontal disease (as well as other risk factors such as
cardiovascular diseases, T2DM and depression), which, in turn,
are risk factors for developing AD (Grant, 2009; Toffanello et al.,
2014a,b). Therefore, monitoring vitamin D levels in populations
such as the elderly, who are at risk of AD, is important. Some
individuals may be at a greater risk to a vitamin D deficiency
because of their dietary choices. For example, vegans could have
lower intakes because they avoid vitamin D rich food such as
fatty fish and free-range eggs, or individuals who live in climates
where exposure to the sun (UV-B radiation) is scarce throughout
the year. More importantly, mature vitamin D results from the
pro-hormone synthesis initiated by UV-B radiation from the sun
and the ability to do so declines during aging. Properly targeted
nutrition, careful sun exposure and supplements can help to
achieve health-supporting values of 25OHD ≥75 nmol/l.
Vitamin B also appears to be important for protecting against
the onset and progression of AD. Inadequate levels of B vitamins
(folate, B12, B6) relate to cognitive impairment and incidence
of dementia in the elderly (Morris, 2012), possibly because
lower levels of these micronutrients elevate plasma homocysteine
(HCys). HCys is a neuro and vasotoxic metabolite that may
lead to impaired S-adenosylmethionine-dependent methylation
reactions, which is vital to CNS functioning (Selhub et al., 2010;
Köbe et al., 2016). Even without clinically manifested deficiency
of vitamin B12, levels in the lower normal range were associated
with poorer memory performance and a reducedmicrostructural
integrity of the hippocampus, a brain area, typically affected first
in AD (Köbe et al., 2016).
Foods like meat, eggs and fish provide sufficient amounts
of vitamin B12 to the body (Cunnane, 2006). Strict vegetarians
on plant foods lacking in B12 must consider supplementing
their diet with B12. However, interventional studies with single
or few nutritional supplements have yielded mixed results
(Eussen et al., 2006; Cunnane et al., 2009; Quinn et al.,
2010; Yurko-Mauro et al., 2010) and one explanation for this
discrepancy maybe that in the elderly, methylation reactions
are less effective. Therefore, some researchers recommend
offering methylated folate and cobalamin to seniors to raise
vitamin B12 or lower homocysteine blood levels (Bredesen,
2014; Hara et al., 2016). In a recent prospective case-control
study, Hara et al. (2016) found patients with AD or related
diseases who took a supplement containing L-methylfolate,
methylcobalamine and N-acetyl-cysteine, showed a noticeable
benefit. The authors suggest that the methylated vitamins are
fully reduced and in bioactive functional form to combat
hyperhomocysteinaemia (Hara et al., 2016). Another nutritional
formulation containing sulfur containing N-acetyl-cysteine and
S-adenosyl-methionine, in addition to vitamins, also showed
some promise in slowing the cognitive decline seen in prodromal
AD cases (Remington et al., 2015). In summary, careful
monitoring of vitamin D and B levels, and dietary interventions
as required, may help to prevent the onset and progression of
AD. Additional research is needed to identify other vitamins and
nutrients, which can support oral health and preserve cognitive
functioning.
Risk Factor Poor Gastrointestinal Tract
Health: Pre/Probiotics
Recently attention has focused on the gut-brain axis and the
role of probiotics in maintaining both physical and mental
health. Diets rich in fruit and vegetables and low in meat are
associated with a greater prevalence of Prevotella species rather
than Bacteroides species, both of which express genes for different
digestive enzymes (Greiner et al., 2014). A vegetarian diet has
been shown to reduce gut inflammation, increasing commensal
microbes and decreasing pathobionts (Kim et al., 2013). This in
turn reduces intestinal lipocalin-2, an adipokine, associated with
inflammation and insulin resistance development (Zhang et al.,
2008; Kim et al., 2013).
Supplementation with probiotics appeared to be useful in the
maintenance of oral health (Krasse et al., 2006); with the daily
consumption of a probiotic milk drink reducing plaque induced
gingival inflammation (Slawik et al., 2011). Furthermore, Riccia
et al. (2007) have shown the probiotic Lactobacillus brevis
to have an anti-inflammatory effect on patients with chronic
periodontitis. However, a recent systematic review concluded
that current probiotics based treatments for periodontal disease
only produce short-term benefits (Jayaram et al., 2016; Bakarcic
et al., 2017). Therefore, further research regarding whether the
long-term prophylactic use of probiotics is useful to support oral
health or whether probiotics to treat active periodontal disease is
desirable.
Probiotics may also reduce the onset of AD by stimulating
the production of GABA, the inhibitory neurotransmitter in the
CNS, via glutamate signaling (Bhattacharjee and Lukiw, 2013).
This is significant as studies performed on post mortem brain
tissues show reduced GABA concentrations in AD patients. In
addition, a recent randomized, double blind, controlled, clinical
trial showed that consumption of a mixture of probiotics over
a 12-week period had a positive effect on cognitive function in
AD patients (Pistollato et al., 2016). Probiotics decrease the levels
of proinflammatory cytokines IL-1β, IL-5, IL-6, IL-8 and TNF-α,
which are upregulated in the elderly, and increase numbers
of activated lymphocytes, natural killer cells and phagocytosis
(Rincon et al., 2014; Wang et al., 2015). All these factors indicate
an improvement in the adaptive immune response, along with
a reduction in inflammation. Overall, it would appear that
probiotics have the potential to provide a beneficial effect on
cognitive decline and oral health. The fact that probiotics show
an anti-inflammatory effect, along with the established GI tract-
brain axis, would provide a possible explanation to this positive
effect and suggest a potential mechanism for a reduction in onset
of AD (Pistollato et al., 2016).
Risk Factor: High Blood Glucose
Not only do patients with T2DM and other states of insulin
resistance show a higher risk of periodontitis, but they also
show a higher risk for AD (Ahmed et al., 2017; Górska et al.,
2017). In addition, high blood glucose emerges as a risk factor
for both diseases (Crane et al., 2013; Miranda et al., 2017).
Crane et al. (2013) reported a study of a large cohort of seniors
without dementia over a period of 6.8 years. After adjusting
for potential confounding variables, participants with higher
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blood glucose readings in the preceding years had a significantly
increased risk of dementia (Crane et al., 2013). The negative
impact of high glucose levels has implications for non-diabetic
elderly individuals who have higher glucose and HbA1c levels on
memory performance, hippocampal volume and microstructure
(Kerti et al., 2013). Therefore, strategies aimed at lowering
glucose levels, not only in diabetics but also individuals with
blood glucose within in the normal range, may beneficially
influence cognition and oral health in the older population. The
best way to achieve optimal blood glucose levels is to reduce
the intake of highly processed carbohydrate rich foods, high
glycaemic carbohydrates and to increase fiber, fat and protein
(Volek et al., 2009).
Risk Factor—Poor Glucose Utilization
Lack of brain insulin or the intact functioning of the insulin
signaling cascade leads to problems with Aβ clearing, learning
and memory, satiety and regulation of feeding behaviors.
Additionally, disturbed glucose utilization is seen as part of
the normal aging process (Yao et al., 2011). Fortunately, the
elderly, including those with mild cognitive impairment and
mild forms of AD, are able to take up ketone bodies, like
β-hydroxybutyrate (BHB) and acetoacetate, through insulin
independent monocarboxylate transporters (Cunnane et al.,
2016). Ketone bodies serve as an alternative and efficient fuel for
neurons and other brain cells, as well as protecting neurons from
oxidative damage.Moreover, the ketone body BHB is able to raise
the levels of brain derived neurotrophic factor (BDNF), which
is important for growth of new neurons in the hippocampus
(Cunnane et al., 2016; Kullmann et al., 2016).
Ketone bodies are metabolites of fatty acid oxidation. The
liver is the main peripheral organ to produce ketone bodies,
but the astrocytes in the brain are also able to build ketones
from medium chain fatty acids (Nonaka et al., 2016; Thevenet
et al., 2016), which are saturated fatty acids with chain lengths of
8–12 carbon atoms (C8–C12). Research on healthy individuals
has shown that small amounts of medium chain triglycerides
(MCTs, 20–30 g C10/d) are able to close an energy gap typically
found in aging individuals (Courchesne-Loyer et al., 2013) and
delay the onset of AD symptoms (Reger et al., 2004). The
achieved degree of ketonemia (ca. 0, 5 mmol/l) was estimated to
contribute to up to 9% of brain energy metabolism. For higher
ketone body levels it would be necessary to eatmoreMCTs, adopt
a strict diet (very low-carbohydrate ketogenic diet) or to fast.
As MCTs, such as those found in virgin coconut oil, are
able to raise ketone body levels mildly, even in the presence
of an ordinary diet, they offer an easy way to achieve supply
of alternative fuel for neurons with compromised glucose
utilization. In a case study, Newport et al. (2015) reported
improvements in a patient with early onset AD using coconut oil,
MCTs and ketone supplements. As even the healthy aging brain
shifts from glucose-driven bioenergetics towards a compensatory
ketogenic pathway (Yao et al., 2011), it seems sensible to use
ketogenic foods (high quality, natural fatty foods and fats)
to reduce the risk of cognitive decline as a result of energy
deficiencies and insulin resistance. Although coconut oil raises
hepatic ketone levels only mildly, it appears beneficial and
potentially helpful for astrocytes to synthesize ketone bodies
and then deliver them to neighboring neurons. A study with
astrocytes in culture demonstrated that lauric acid (C12), the
major medium chain saturated fatty acid constituent of coconut
oil, is able to cross the BBB and activate ketogenesis in astrocytes
(Nonaka et al., 2016). Alternatively, oil pulling (whereby oil is
held in the mouth) with coconut oil was able to reduce the
S. mutans populations in saliva, and this could be a means to
aid the maintenance of oral health (Kaushik et al., 2016). A
preliminary report by Peedikayil et al. (2015) described the effects
of oil pulling with coconut oil, which contains a high proportion
of the anti-inflammatory and antimicrobial compound lauric
acid. It led to a decrease in plaque formation and improved
gingival indices after 30 days of its application in African
adolescents.
LIFE STYLE CHOICES
Risk Factor: Smoking
Smoking tobacco increases the severity with which periodontal
disease progresses. For example, the use of nicotine is shown
to select for periodontal pathogens, including P. gingivalis,
Treponema denticola and Tannerella forsythia, which will
encourage progression of this oral disease (Zambon et al., 1996).
The periodontal indices change dramatically, as smoking not
only leads to harboring higher proportions of oral bacteria that
colonize rapidly, but also encourages colonization of species of
the more virulent, red complex pathogens such as T. forsythia
and P. gingivalis strains than not smoking (Kamma et al., 1999).
The highly virulent forms of T. forsythia and P. gingivalis in
greater numbers are capable of maintaining severe inflammation,
and their invasive property continues to exacerbate pathology of
the periodontium (Kamma et al., 1999; Bergström, 2004). The
inflammation arising from the microbes which result from poor
hygiene along with secondary mediators from bone regulatory
factors (Takahashi, 2005; Olsen et al., 2016) and the innate
immune response in smokers ultimately succumb to a higher
rate of alveolar bone erosion (Grossi et al., 1995). Therefore,
inflammatory burden due to smoking (Kamma et al., 1999) can
undermine the developing chronicity of periodontitis alongside
the impact on health of the distant organs affected by periodontal
pathogens.
Risk Factor: Drinking Alcohol
Drinking alcohol can lead to a moderate increase in the
risk of periodontal disease (Tezal et al., 2004; Genco and
Borgnakke, 2013). High alcohol consumption affects the innate
immune system in a negative manner; with chronic alcohol
consumption being predictive of higher levels of inflammatory
markers (McDade et al., 2006; Barr et al., 2016). Conversely,
drinking alcohol in moderation is thought to reduce periodontal
disease, by a positive effect on the innate immune system,
and so, reduce the risk of vascular diseases, and AD. In
addition, moderate amounts of wine (Evers et al., 2009) can have
beneficial anti-inflammatory effects and so may reduce the risk
of developing chronic diseases, such as periodontitis and AD.
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Risk Factor: Poor Sleep
Recent research by Sprecher et al. (2017) has highlighted the
link between poor sleep and AD development. The study found
higher levels of pre-clinical AD biomarkers in cerebrospinal fluid
samples in people reporting several measures of poor sleep such
as higher levels of daytime somnolence. Therefore, attending to
good sleep hygiene is an important preventative measure against
AD development (Harding et al., 2017). Specifically, adequate
sleep in advancing age is important for retaining memory, and
for the effective functioning of the glymphatic system mediated
cleansing of the brain (Iliff et al., 2013). The HPA axis has been
shown to play a role in the maintenance of sleep/wake patterns.
Infections from dysbiotic microbiomes including the GI tract
microbiome will modulate the HPA through changes in the
neurochemicals and inflammatory mediators (Galland, 2014).
For example, proinflammatory cytokines are potent inducers
of non-rapid eye movement (nREM) sleep (Galland, 2014).
Deterioration of the circadian system that controls sleep/wake
cycles in the elderly may contribute to the excess accumulation
of abnormal proteins in AD brains and impairments to the
glymphatic cleansing system (Yesavage et al., 2003). Active
periodontal disease and reduced glymphatic system functioning,
due to restricted sleep periods, can also impair the brain’s ability
to clear microbes, such as P. gingivalis (Harding et al., 2017).
Furthermore, there is some evidence to suggest P. gingivalis, the
keystone pathogen of chronic periodontitis, accesses the brains
of experimental mice (Poole et al., 2015; Singhrao et al., 2017),
and can disturb the microglial cell day/night activity (Takayama
et al., 2016). This implies that P. gingivalis infection through
chronic periodontitis can further contribute to poor quality
sleep.
Humans are diurnal mammals and hence many of their
metabolic activities have evolved for activity and storage during
the day, and rest, repair and use of stored nutrients during the
night. This is supported by hormonal rhythms, like themelatonin
rhythm, which is mainly regulated by light and heavily disturbed
by blue wavelength emitting devices like smartphones, tablets,
TV screens and e-readers (Heo et al., 2017). The daily rhythms
make us more insulin resistant in the evening and during the
night (Carrasco-Benso et al., 2016; Morris et al., 2016), therefore
large dinners, especially those with a heavy carbohydrate load
should be avoided in the evening when the body is meant to fast
and to use stored fats. In addition, a heavy dinner can disturb
sleep and impair sleep quality. Therefore, it is recommended that
people fast for at least 3 h before going to bed and to reduce the
carbohydrate content, especially of the evening meal (Bredesen,
2014).
Other dietary interventions found to help promote sleep
include, avoiding caffeine-containing foods and drinks, if not
well tolerated, before bedtime, and alcohol, which can increase
sleepiness but disturbs regenerative deep sleep phases (Ebrahim
et al., 2013; Clark and Landolt, 2017). Alternatively, eating
cherries or kiwifruits can promote sleep via their naturally high
levels of melatonin (Pigeon et al., 2010; Lin et al., 2011). Drinking
milk before bed may also increase drowsiness due to its high level
of tryptophan and B vitamins (Peuhkuri et al., 2012). Finally,
exercise taken during the day can have a positive impact on sleep,
especially when undertaken outside in natural daylight (Reid
et al., 2010).
FUTURE PERSPECTIVES
It is important to recognize the impact of environmental factors
on the mental health outcomes of the elderly. Specifically, we
argue that nutrition and subsequent impact on oral health, often
overlooked should be a priority. Although, oral health may be
less of a priority, when compared to the management of other
conditions associated with old age, it is clear that poor oral health
may cause or aggravate other conditions such as T2DM, which
in turn could be the risk factors in AD development. Given
the importance of maintaining good oral health, an increase
in services, which improve the community based geriatric care
culture, are needed. Future health professionals, during their
early training years, should pay visits to nursing homes to mix
with the residents and better their relationship with the elderly
residents. Improved funding and resources should be considered
to prioritize the elderly for oral health promotion and screening
programmes, identifying them as a group that are currently of
seemingly low priority, whose longevity and improved quality
of life, morbidity and mortality may be significantly enhanced
with provision of education and support to both the elderly
and their care teams. Community based oral health care should
become compulsory for nursing homes. Input from nutritionists
should be considered to support healthier diets for the elderly
that improve oral health.
CONCLUSION
Maintaining healthy oral and GI tract microbiomes is of great
benefit to the host. It appears that the oral dysbiotic biofilm
contributes to factors that initiate pathogenesis of disease both
locally and at distant organ sites remote from the GI tract.
The mechanism by which oral pathogens cause destruction
is via subversion of immune responses and by differential
inflammatory signaling pathway activation. The GI tract
dysbiotic microbes appear to display features related to behavior.
The cross-links involve the endocrine pathway proteins, such as
GABA, serotonin, stress hormones, along with various others.
This is because GI tract microbiome bacteria are enriched in
neurochemicals and are involved in local upkeep through sensory
vagus nerve signaling pathways with the brain. One explanation
may be that the loss of neurochemicals through a changing
microbiome consortium cannot feedback, the information to the
brain to keep control over ongoing inflammation. These balances
need to be maintained by overcoming nutritional deficits that life
styles, especially those associated with the progress of aging, may
have introduced into daily life.
The current article discusses nutritional factors, including the
benefits of adopting a calorically appropriate, low-carbohydrate,
adequate protein and fat containing diet which appear to be
the best way to prevent and/or delay the progression of both
periodontal disease and AD. Virgin coconut oil and MCTs
supplements provide ketone bodies which can support the brain,
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and help to improve oral microbiota. The current article also
discusses multiple shared risk factors of periodontitis and AD in
relation to their co-morbid status development. One important
dental aspect highlighted at least a decade ago, but taken
little notice of, is how fewer teeth alter people’s eating habits
and their dietary choices, which impacts on oral, metabolic,
GI tract and brain health. In the context of a multifactorial
intervention (MENDTM programme), a lower carbohydrate diet
supplemented with virgin coconut oil or MCT-Oils, fish or
omega-3 fatty acids, selected nutrients or phytochemicals along
with, for example, improvements in oral hygiene and sleep
were necessary to improve oral health. These have already
shown promise in delaying and even reversing symptoms of
mild cognitive decline and AD (Bredesen, 2014; Bredesen et al.,
2016). In conclusion, more research is needed to evaluate
the effectiveness of diet-based interventions in supporting oral
health, and to assess the potential impact of nutrition on AD
onset and progression.
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